OR
Publications
3
Views
64
Downloads
35
Supervised works
0
Items per page
1 - 3 of 3
Title Published in Access level OA Policy Year Views Downloads
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid TumorsCancer research communications
accessLevelPublic
2024 24 19
LBA46 SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapyESMO Congress 2023
accessLevelPublic
2023 11 6
Personalized immunotherapy with encapsulated cell technology : Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumorsESMO Congress 2022
accessLevelPublic
2022 29 10
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack